IP Library Granted Patent US 11,104,687
Granted Patent B2
US 11,104,687 · App. 16/598,411 · Granted Aug 31, 2021

Solid forms for a thienopyrimidinedione ACC inhibitor and methods for production thereof

Inventors: Geraldine C. Harriman (Charlestown, RI); Jon P. Lawson (Cambridge, MA); Xiaowei Yang (Foster City, CA)
Assignee: Gilead Apollo, LLC
C07D495/04A61K31/519A61P1/16A61P3/00A61P3/06C07D309/12C12P41/001C12Y301/01003C07B2200/13
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,104,687
App. No.
16/598,411
Granted
Aug 31, 2021
Kind
B2
Abstract

The present invention provides solid forms of compounds useful as inhibitors of Acetyl CoA Carboxylase (ACC), compositions thereof, methods of producing the same, and methods of using the same in the treatment of ACC-mediated diseases.

Claims (14)

1. A process for preparing an enantiomerically enriched compound of formula (R)-G-5:

wherein R a is an optionally substituted group selected from a 3-7 membered ring having 0-2 heteroatoms selected from nitrogen, oxygen, and sulfur, and C 1-6 aliphatic;

R 2 is hydrogen or optionally substituted C 1-6 aliphatic; and

R 5 is hydrogen or halogen;

comprising the steps of:

a) contacting a racemic compound of formula rac-G-5

with a lipase enzyme and a [acyl] donor, thereby forming a compound of formula (R)-G-8:

wherein [acyl] is a C 1 -C 7 acyl group; and

b) removing the [acyl];

thereby preparing the enantiomerically enriched compound of formula (R)-G-5.

2. The process of claim 1 , wherein the compound of formula (R)-G-5 is (R)-G-5-a:

3. The process of claim 1 , wherein the [acyl] donor is an optionally substituted 4-7 membered lactone or 4-7 membered optionally substituted cyclic anhydride; or a compound of the formula R x C(O)OR y , wherein R′ is optionally substituted C 1-4 aliphatic; and R y is optionally substituted C 1-4 aliphatic or optionally substituted C 1-4 acyl.

4. The process of claim 3 , wherein [acyl] is a C 4 acyl group.

5. The process of claim 3 , wherein the lipase enzyme is Candida antarctica lipase B.

Assignments (18)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2019
From: ALEXANDER, KATY
To: SOLID FORM SOLUTIONS LIMITED
Reel/Frame 050840/0400 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2019
From: AMEDIO, JOHN C.
To: AMEDIO CMC CONSULTING, LLC
Reel/Frame 050840/0469 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2019
From: CALIMSIZ, SELCUK; GEIER, MICHAEL; SABOURIN, KYLE; SCOTT, MARK E.; VARGHESE, VIMAL; WANG, XIAOTIAN; MORRISON, HENRY
To: GILEAD SCIENCES, INC.
Reel/Frame 050840/0587 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2019
From: AMEDIO CMC CONSULTING, LLC
To: NIMBUS DISCOVERY, INC.
Reel/Frame 050840/0667 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2019
From: HARRIMAN, GERALDINE C.
To: NIMBUS DISCOVERY, INC.
Reel/Frame 050840/0677 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2019
From: HU, SIJUN
To: PHARMARON BEIJING CO., LTD.; PHARMARON, INC.
Reel/Frame 050840/0720 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2019
From: VARIA, KUNAL A.
To: SOLID FORM SOLUTIONS LIMITED
Reel/Frame 050841/0131 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2019
From: LAWSON, JON P.
To: J.P. LAWSON CONSULTING LLC
Reel/Frame 050841/0199 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2019
From: J.P. LAWSON CONSULTING LLC
To: PHARMACEUTICAL ADVISORS LLC
Reel/Frame 050841/0305 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2019
From: PHARMACEUTICAL ADVISORS LLC
To: NIMBUS APOLLO, INC.
Reel/Frame 050841/0343 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2019
From: YANG, XIAOWEI
To: PHARMARON BEIJING CO., LTD.; PHARMARON, INC.
Reel/Frame 050841/0385 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2019
From: NIMBUS DISCOVERY, INC.
To: NIMBUS APOLLO, INC.
Reel/Frame 050841/0392 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2019
From: SOLID FORM SOLUTIONS LIMITED
To: NIMBUS APOLLO, INC.
Reel/Frame 050841/0408 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2019
From: PHARMARON BEIJING CO., LTD.; PHARMARON, INC.
To: PHARMARON, INC.
Reel/Frame 050841/0485 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2019
From: PHARMARON, INC.
To: NIMBUS APOLLO, INC.
Reel/Frame 050841/0553 →
CHANGE OF NAME Recorded Oct 28, 2019
From: NIMBUS APOLLO, INC.
To: GILEAD APOLLO, INC.
Reel/Frame 050841/0672 →
MERGER AND CHANGE OF NAME Recorded Oct 28, 2019
From: GILEAD APOLLO, INC.; GILEAD APOLLO, LLC
To: GILEAD APOLLO, LLC
Reel/Frame 050841/0697 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2019
From: GILEAD SCIENCES, INC.
To: GILEAD APOLLO, LLC
Reel/Frame 050841/0767 →
Continuity (5)
Division 16217935 · Dec 12, 2018
Division 15446873 · Mar 1, 2017
Provisional Application 62303237 · Mar 3, 2016
Provisional Application 62302755 · Mar 2, 2016
Related Publication 20200148699A1 · May 14, 2020